MyAV范

The MyAV范 Institute of Ophthalmology (IoO) and Santen, a world-leading ophthalmic pharmaceutical company based in Japan, have agreed to develop a new research unit to support investigation into how to prevent and reverse damage caused to the optic nerve and retina by glaucoma.

The new initiative represents Santen鈥檚 first research laboratory in Europe, and the lab聽will facilitate even greater collaboration between Santen and MyAV范 IoO scientists, allowing deeper research on projects of mutual interest.

This is the latest development in the long-standing relationship between MyAV范 and Santen, where Santen has been supporting the IoO with PhD studentships, symposia, and networking opportunities over the last few years, with facilitation from MyAV范鈥檚 Japan ambassador and IoO Professor Shin-Ichi Ohnuma.聽

The new research unit has recruited two dedicated post-doctoral scientists to launch the new initiative, including MyAV范 student Will Lamb, who recently completed his PhD studies with sponsorship from Santen and will continue to carry out his research while embedded within the IoO.

MyAV范 IoO Director,聽Professor Andrew Dick聽said: 鈥淭his is an exciting new development in our strategic partnership with Santen, which has been going from strength to strength since the original memorandum-of-understanding in 2016. I鈥檓 grateful to everyone involved for their enthusiasm and dedication to foster the research potential of this partnership; and to MyAV范 Translational Research Office for supporting the IoO鈥檚 vision to expand our translational research to generate better therapies, diagnostics and knowledge of eye care.鈥�

The MyAV范 Translational Research Office (TRO) has been supporting and facilitating this collaboration with the understanding of the overall intent of breaking down industry/academic silos by continuing to contribute to the pursuit of therapeutic translational excellence and to training the next generation.

Dr Jane Kinghorn,聽MyAV范 TRO Director said: 鈥淪anten has made a large investment in ophthalmology training & research at the IoO. This research collaboration is an evolution of that commitment with the first Santen employee embedded within the institution. We look forward to supporting this collaboration in the years to come with many more joint research collaboration projects joining the managed portfolio.鈥�

Luis Iglesias,聽President and Head of Santen EMEA said: 鈥淚 am delighted to have established a new European research laboratory at the MyAV范 Institute of Ophthalmology in London. The investigations that will now take place in the United Kingdom bring us a step closer to finding new solutions for eye diseases and complements work ongoing around the world in our research hubs in Singapore and Japan.鈥�

More information

• New MyAV范 IoO/Santen research collaboration
• MyAV范 Institute of Ophthalmology
• MyAV范 Translational Research Office (TRO)聽
• Santen and MyAV范 to collaborate on ophthalmic research and education

For the latest news about MyAV范鈥檚 international activity, partnerships and opportunities, subscribe to the聽bimonthly聽Global Update newsletter.